Cost of active ACC claims for adverse reactions to medications in New Zealand
Year ended June 2011–2018, NZD millions
Year ended June | NZD |
---|---|
2011 | 6,237,684 |
2012 | 6,448,323 |
2013 | 6,400,904 |
2014 | 8,164,929 |
2015 | 8,753,586 |
2016 | 10,059,895 |
2017 | 12,178,762 |
2018 | 13,185,542 |